Brookstone Capital Management Buys Shares of 6,892 Merit Medical Systems, Inc. $MMSI

Brookstone Capital Management bought a new position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 6,892 shares of the medical instruments supplier’s stock, valued at approximately $574,000.

A number of other institutional investors have also made changes to their positions in the stock. Maseco LLP acquired a new position in shares of Merit Medical Systems in the 2nd quarter worth approximately $28,000. MassMutual Private Wealth & Trust FSB raised its position in Merit Medical Systems by 55.6% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 375 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 134 shares during the period. Northwestern Mutual Wealth Management Co. raised its position in Merit Medical Systems by 119.8% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 367 shares of the medical instruments supplier’s stock valued at $39,000 after purchasing an additional 200 shares during the period. Bayforest Capital Ltd acquired a new position in Merit Medical Systems during the first quarter worth $41,000. Finally, EverSource Wealth Advisors LLC boosted its position in shares of Merit Medical Systems by 745.9% during the second quarter. EverSource Wealth Advisors LLC now owns 922 shares of the medical instruments supplier’s stock worth $86,000 after buying an additional 813 shares during the period. 99.66% of the stock is currently owned by institutional investors and hedge funds.

Merit Medical Systems Price Performance

Shares of NASDAQ MMSI opened at $88.56 on Wednesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 4.28 and a quick ratio of 2.86. The company has a market cap of $5.25 billion, a price-to-earnings ratio of 45.42, a price-to-earnings-growth ratio of 2.82 and a beta of 0.61. The stock’s 50-day moving average is $86.06 and its two-hundred day moving average is $86.72. Merit Medical Systems, Inc. has a 1-year low of $78.12 and a 1-year high of $111.45.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Thursday, October 30th. The medical instruments supplier reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.10. Merit Medical Systems had a return on equity of 14.27% and a net margin of 8.02%.The business had revenue of $384.16 million during the quarter, compared to analysts’ expectations of $371.69 million. During the same quarter last year, the business posted $0.86 EPS. The business’s quarterly revenue was up 13.0% compared to the same quarter last year. Merit Medical Systems has set its FY 2025 guidance at 3.660-3.790 EPS. Analysts forecast that Merit Medical Systems, Inc. will post 3.37 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $108.00 price objective on shares of Merit Medical Systems in a research note on Friday, October 31st. Barrington Research restated an “outperform” rating and set a $106.00 target price on shares of Merit Medical Systems in a report on Friday, November 14th. Wells Fargo & Company dropped their target price on Merit Medical Systems from $103.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday, November 14th. Robert W. Baird set a $108.00 price target on shares of Merit Medical Systems in a research note on Tuesday, December 16th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Merit Medical Systems in a research note on Monday. Eight investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $105.88.

Insider Transactions at Merit Medical Systems

In other Merit Medical Systems news, Chairman Fred P. Lampropoulos sold 25,000 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $87.31, for a total transaction of $2,182,750.00. Following the completion of the transaction, the chairman owned 1,029,955 shares in the company, valued at $89,925,371.05. The trade was a 2.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders have sold a total of 60,000 shares of company stock valued at $5,189,900 in the last ninety days. 3.70% of the stock is owned by insiders.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.